These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 15730856)
61. [Synergistic cytotoxic effects of chemotherapy in colon tumor cells by simultaneous inhibition of de novo and salvage energy metabolism pathways]. Szekeres T; Fritzer M; Schön HJ; Findenig G; Lhotka C Wien Klin Wochenschr; 1994; 106(14):459-63. PubMed ID: 7941593 [TBL] [Abstract][Full Text] [Related]
62. Tiazofurin action in leukemia: evidence for down-regulation of oncogenes and synergism with retinoic acid. Weber G; Yamaji Y; Nagai M; Natsumeda Y; Jayaram HN; Zhen WN; Paulik E Adv Enzyme Regul; 1990; 30():35-45. PubMed ID: 2206022 [TBL] [Abstract][Full Text] [Related]
63. Biochemical modulation of aracytidine (Ara-C) effects by GTI-2040, a ribonucleotide reductase inhibitor, in K562 human leukemia cells. Chen P; Aimiuwu J; Xie Z; Wei X; Liu S; Klisovic R; Marcucci G; Chan KK AAPS J; 2011 Mar; 13(1):131-40. PubMed ID: 21191677 [TBL] [Abstract][Full Text] [Related]
64. Resveratrol, an antioxidant present in red wine, induces apoptosis in human promyelocytic leukemia (HL-60) cells. Surh YJ; Hurh YJ; Kang JY; Lee E; Kong G; Lee SJ Cancer Lett; 1999 Jun; 140(1-2):1-10. PubMed ID: 10403535 [TBL] [Abstract][Full Text] [Related]
65. Induction of HL60 cell differentiation by tiazofurin and its analogues: characterization and efficacy. Goldstein BM; Leary JF; Farley BA; Marquez VE; Levy PC; Rowley PT Blood; 1991 Aug; 78(3):593-8. PubMed ID: 1650262 [TBL] [Abstract][Full Text] [Related]
66. The ribonucleotide reductase inhibitor trimidox induces c-myc and apoptosis of human ovarian carcinoma cells. Rosenberger G; Fuhrmann G; Grusch M; Fassl S; Elford HL; Smid K; Peters GJ; Szekeres T; Krupitza G Life Sci; 2000 Nov; 67(26):3131-42. PubMed ID: 11191620 [TBL] [Abstract][Full Text] [Related]
67. Isolation of apoptosis- and differentiation-inducing substances toward human promyelocytic leukemia HL-60 cells from leaves of Juniperus taxifolia. Muto N; Tomokuni T; Haramoto M; Tatemoto H; Nakanishi T; Inatomi Y; Murata H; Inada A Biosci Biotechnol Biochem; 2008 Feb; 72(2):477-84. PubMed ID: 18256464 [TBL] [Abstract][Full Text] [Related]
68. Action of resveratrol alone or in combination with roscovitine, a CDK inhibitor, on cell cycle progression in human HL-60 leukemia cells. Komina O; Wesierska-Gadek J Biochem Pharmacol; 2008 Dec; 76(11):1554-62. PubMed ID: 18761329 [TBL] [Abstract][Full Text] [Related]
69. In AML cell lines Ara-C combined with purine analogues is able to exert synergistic as well as antagonistic effects on proliferation, apoptosis and disruption of mitochondrial membrane potential. Chow KU; Boehrer S; Napieralski S; Nowak D; Knau A; Hoelzer D; Mitrou PS; Weidmann E Leuk Lymphoma; 2003 Jan; 44(1):165-73. PubMed ID: 12691159 [TBL] [Abstract][Full Text] [Related]
70. [Effects of RhG-CSF on apoptosis of HL-60 cell induced by cytarabine]. Wang H; Sun LR; Li L Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec; 13(6):996-8. PubMed ID: 16403266 [TBL] [Abstract][Full Text] [Related]
71. Anti-leukemia effect of resveratrol. Tsan MF; White JE; Maheshwari JG; Chikkappa G Leuk Lymphoma; 2002 May; 43(5):983-7. PubMed ID: 12148909 [TBL] [Abstract][Full Text] [Related]
72. Potentiation of antimetabolite action by dibromodulcitol in cell culture. Oláh E; Kremmer T; Boldizsár M Adv Enzyme Regul; 1985; 24():155-75. PubMed ID: 3835819 [TBL] [Abstract][Full Text] [Related]
73. Time- and concentration-dependent effects of resveratrol in HL-60 and HepG2 cells. Stervbo U; Vang O; Bonnesen C Cell Prolif; 2006 Dec; 39(6):479-93. PubMed ID: 17109633 [TBL] [Abstract][Full Text] [Related]
74. Effects of naturally occurring stilbene glucosides from medicinal plants and wine, on tumour growth and lung metastasis in Lewis lung carcinoma-bearing mice. Kimura Y; Okuda H J Pharm Pharmacol; 2000 Oct; 52(10):1287-95. PubMed ID: 11092574 [TBL] [Abstract][Full Text] [Related]
75. Effects of N-hydroxy-N'-aminoguanidine isoquinoline in combination with other inhibitors of ribonucleotide reductase on L1210 cells. Weckbecker G; Weckbecker A; Lien EJ; Cory JG J Natl Cancer Inst; 1988 Jun; 80(7):491-6. PubMed ID: 2452889 [TBL] [Abstract][Full Text] [Related]
76. Cell cycle dependent regulation of IMP dehydrogenase activity and effect of tiazofurin. Szekeres T; Fritzer M; Pillwein K; Felzmann T; Chiba P Life Sci; 1992; 51(16):1309-15. PubMed ID: 1357518 [TBL] [Abstract][Full Text] [Related]
77. Critical issues in chemotherapy with tiazofurin. Weber G Adv Enzyme Regul; 1989; 29():75-95. PubMed ID: 2699155 [TBL] [Abstract][Full Text] [Related]
78. Cell cycle-dependent cytotoxicity and induction of apoptosis by liposomal N4-hexadecyl-1-beta-D-arabinofuranosylcytosine. Horber DH; von Ballmoos P; Schott H; Schwendener RA Br J Cancer; 1995 Nov; 72(5):1067-73. PubMed ID: 7577448 [TBL] [Abstract][Full Text] [Related]
79. Schedule-dependent synergistic action of tiazofurin and dipyridamole on hepatoma 3924A cells. Jayaram HN; Murayama K; Pillwein K; Zhen W; Weber G Cancer Chemother Pharmacol; 1992; 31(2):93-6. PubMed ID: 1451238 [TBL] [Abstract][Full Text] [Related]
80. Synergistic down-regulation of signal transduction and cytotoxicity by tiazofurin and quercetin in human ovarian carcinoma cells. Shen F; Herenyiova M; Weber G Life Sci; 1999; 64(21):1869-76. PubMed ID: 10353585 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]